A Mellanox (MLNX) insider bought $2.2 million of the Israeli chip designer as fears China will block a proposed merger with Nvidia Corp (NVDA) pushed the price of MLNX well below the buyout price. Stephen Sanghi, a director of Sunnyvale-based Mellanox since February...
Twenty-two minutes after regular market hours closed on July 2, an Orbimed Advisors Form 4 relating to Corvus Pharmaceuticals Inc (CRVS) was posted on the SEC's website. The hedge fund, a 10%+ holder and insider in CRVS, disclosed that between June 27 and July 1 it...
Benjamin Graham activist investor. That's not a term we often hear. Usually Ben Graham is referred to as "The Father of Value Investing." He's the man who coined the term "margin of safety" -- minimizing risk and maximizing profits by buying stocks at deep discounts to intrinsic...
In a 13D filed Friday after market hours, Ault Global disclosed a 9.96% position in NTN Buzztime (NTN), a provider of interactive entertainment to sports bars and other venues across North America. Ault called NTN "undervalued and represented an attractive investment opportunity." On Jan....
Starboard Value cut its Cars.com stake aggressively after the online auto retailer's strategic search failed and the company announced disappointing Q2 results. In a 13D/A filing submitted Wednesday afternoon, the hedge fund disclosed selling 4.47 million shares of the online automobile retailer on August 5-6 at...
By Mark W. Gaffney For WhaleWisdom.com As of May 1, 2018, over 5,200 stock positions were held by the 55 funds classified as activist investors. That’s according to data from WhaleWisdom.com. Most of these stocks will be unremarkable performers, generating little alpha for the fund or investors. But hidden among the many...
Cloning Carl Icahn is a good idea. Now I'm of course not talking about a laboratory experiment whereby we create an army of little corporate activists that will grow into so many billionaires. Rather, I'm referring to following the renowned...
Newell Brands (NWL) stock tumbled 22% over three days, but a long-time lieutenant of activist investor Carl Icahn was buying, picking up $1 million worth on August 8 at $20.50. In total, 3 directors of NWL bought $1.7 million of stock into the downdraft. The purchases were disclosed in Form 4 filings submitted today.
Billionaire Mori Arkin filed a 13D on Aclaris Therapeutics (ACRS), a development stage microcap biotech company with a promising treatment for common warts. Arkin bought the shares through his personal partnership, "The 1999 Company." In the activist filing he disclosed the following trades: Purchase/SaleSharesPriceDate Running ...
A.H. Belo (AHC) was the target Wednesday afternoon of a 13D filing by Minerva Advisors LLC. The hedge fund disclosed a 5.1% activist ownership position in the publisher of the Dallas Morning News, and said the company should go private. From the 13D filing: